From Xconomist of the Week: NPS’s Francois Nader Shares Lessons Learned:

Francois Nader

Francois Nader—

NPS Pharmaceuticals CEO Francois Nader is an Xconomist.

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Sponsored · Whitepaper
Decentralized Clinical Trials: The Call for a New Paradigm
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!